-
Lancet Diabetes Endocrinol · Oct 2020
LetterDraft FDA guidance for assessing the safety of glucose lowering therapies: a missed opportunity?
- Kamlesh Khunti, Melanie J Davies, Nikolaus Marx, and John B Buse.
- Diabetes Research Centre, University of Leicester, Leicester LE5 4PW, UK. Electronic address: kk22@le.ac.uk.
- Lancet Diabetes Endocrinol. 2020 Oct 1; 8 (10): 810-811.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..